Posts
Bctx could there be a squeeze coming no shares high ctb 178%1.2 to 1.6 dtc
So bctx ran on great news from mastiatic breast cancer stock ran then bam came the public offering bctxl warrants expiring in 2031 already trading over 1$ so are shorts still trapped like ai is saying? Before the offering there was high si and cost to borrow almost 200% with …
$REVB: Major FDA Win: Single Study Pathway for Gemini (AKI) Approved 🚀
Ticker: REVB (Revelation Biosciences) Sector: Biotech / Renal Health Current Price (PM): \~$1.18 (+38% spike) The Catalyst: Why is it moving? Revelation Biosciences just dropped a massive PR announcing they have reached an agreement with the FDA on a simplified approval pathway for their lead candidate, Gemini, for treating Acute …
ImmunityBio Reports Median Overall Survival Not Yet Reached and Lymphopenia Reversed in Recurrent Glioblastoma Patients Receiving ANKTIVA® Plus CAR-NK, Chemo-Free Therapy
Borrow rate spikes 104% on Robinhood rocket about to explode 🚀💣
Datavault AI is ripping! Squeeze imminent!
AEHL low float bottom. Low borrow.
AEHL's last major run from these levels hit $4 plus. Well, we are back to bottom again. This is a factory reboot if you will. Small capture flying. This one is famous. Right now we are officially an accumulation once this breaks resistance and the 150s. We should see a …